jama semaglutide naion may raise risk for nonarteritic anterior ischemic optic neuropathy in diabetes Non Arteritic Ischemic Optic Neuropathy

I think doctors, the NHS, everyone, just need to be more aware of what is out there and what can actually help.

These data suggest a potential role for GLP-1 receptor agonists in both the prevention and the treatment of various SUDs, according to the study authors

For the treatment of gastrointestinal issues, it is recommended to take this medicine on an empty stomach or before having meals, because it raises the absorption and efficacy of the medicine

Though human clinical trials are ongoing, signs point to BPC-157 being safe

Saves time on manual computations and unit conversions (mg, mcg, IU)

Maybe you didnt shotgun a green beer, but you had a couple Irish whiskeys at the party last night